+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Implantable Cardioverter Defibrillators Market by Product Type, by Type, by NYHA Class, by End-User, and By Region

  • PDF Icon

    Report

  • 200 Pages
  • March 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5941875
The global implantable cardioverter defibrillators market size was estimated to be USD 3.87 billion in 2023 and is expected to reach USD 7.69 billion by 2034 with a CAGR of 6.44% during the forecast period 2024-2034. The market will increase as a result of rising patient preference for implantable devices, government initiatives and funding, awareness and education campaigns, rising incidence of cardiovascular diseases, and technological advancements.

One major factor propelling the ICD market is the increasing incidence of cardiovascular disorders, which includes arrhythmias and sudden cardiac arrest. ICD demand is predicted to rise as the world's population ages and lifestyle choices lead to an increase in heart-related problems. For instance, in August 2023, Medtronic released the improved diagnostic capabilities of the Micra VR implanted heart monitor.

By product type, the transvenous implantable cardioverter-defibrillators (ICDs) segment accounted for the highest revenue-grossing segment in the global implantable cardioverter defibrillators market in 2023 owing to the technological advancements, established procedural efficacy, and widespread acceptance among healthcare professionals and patients. For instance, in October 2023, Boston Scientific received FDA certification for its InSync Duo defibrillator, which has an enhanced leadless design and sophisticated diagnostics. Additionally, the subcutaneous implantable cardioverter defibrillators (S-ICDs) segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing emphasis on patient comfort, reduced risk of infection, and advancements in subcutaneous implantable cardioverter-defibrillator (S-ICD) technology.

By type, the single chamber ICDs segment accounted for the highest revenue-grossing segment in the global implantable cardioverter defibrillators market in 2023 owing to the growing prevalence of specific clinical indications, such as bradycardia and certain tachyarrhythmias, aligning well with the targeted therapeutic capabilities of single-chamber implantable cardioverter-defibrillators (ICDs). For instance, Abbott Laboratories is working with Verily, an Alphabet company, to create AI-powered algorithms for better ICD treatment administration and arrhythmia diagnosis. Additionally, the dual-chamber ICDs segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing recognition of the clinical benefits offered by dual-chamber implantable cardioverter-defibrillators (ICDs), particularly in addressing complex arrhythmias and optimizing hemodynamic performance.

By NYHA class, the NYHA class II segment accounted for the highest revenue-grossing segment in the global implantable cardioverter defibrillators market in 2023 owing to the increased prevalence of heart failure cases falling within the New York Heart Association (NYHA) Class II category, coupled with the growing recognition of implantable cardioverter-defibrillators (ICDs) as an effective therapeutic intervention for this specific patient population. For instance, in December 2022, BIOTRONIK SE & Co. KG received FDA clearance for their MagPro2 MRI defibrillator system, which allows some patients to get MRI compatibility. Additionally, the NYHA class III segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing recognition of the therapeutic benefits offered by implantable cardioverter-defibrillators (ICDs) in managing advanced heart failure cases falling within the New York Heart Association (NYHA) Class III category.

By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global implantable cardioverter defibrillators market in 2023 owing to the significant volume of implantable cardioverter-defibrillator (ICD) procedures performed in hospital settings, reflecting the central role of hospitals in the diagnosis, treatment, and management of cardiovascular diseases. For instance, in August 2023, MicroPort Scientific Corporation and Philips announced a strategic alliance to distribute MicroPort's ICDs in Europe and other global markets. Additionally, the ambulatory surgical centers (ASCs) segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend toward outpatient procedures, advancements in implantable cardioverter-defibrillator (ICD) technologies that facilitate minimally invasive interventions, and the emphasis on cost-effective healthcare delivery.

North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, a high prevalence of cardiovascular diseases, early adoption of advanced medical technologies, and supportive reimbursement policies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising awareness of cardiovascular health, increasing healthcare expenditure, expanding healthcare infrastructure, and a growing aging population. For instance, in September 2023, LivaNova PLC reported encouraging preliminary findings from a clinical trial assessing the effectiveness of their EnRhythm ICDs in the treatment of atrial fibrillation.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Product Type, Type, NYHA Class, and End-User
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement.

Segmentation: Implantable Cardioverter Defibrillators Market Report 2023 - 2034

Implantable Cardioverter Defibrillators Market Analysis & Forecast by Product Type 2023 - 2034 (Revenue USD Bn)

  • Transvenous Implantable Cardioverter-Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators

Implantable Cardioverter Defibrillators Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)

  • Single Chamber ICDs
  • Dual Chamber ICDs
  • Biventricular Devices

Implantable Cardioverter Defibrillators Market Analysis & Forecast by NYHA Class 2023 - 2034 (Revenue USD Bn)

  • NYHA Class II
  • NYHA Class III

Implantable Cardioverter Defibrillators Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Implantable Cardioverter Defibrillators Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Implantable Cardioverter Defibrillators Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Implantable Cardioverter Defibrillators Market: Product Type Estimates & Trend Analysis
7.1. Product Type Segment Opportunity Analysis
7.2. Transvenous Implantable Cardioverter-Defibrillators
7.2.1. Transvenous Implantable Cardioverter-Defibrillators Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Subcutaneous Implantable Cardioverter Defibrillators
7.3.1. Subcutaneous Implantable Cardioverter Defibrillators Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Implantable Cardioverter Defibrillators Market: Type Estimates & Trend Analysis
8.1. Type Segment Opportunity Analysis
8.2. Single Chamber ICDs
8.2.1. Single Chamber ICDs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Dual Chamber ICDs
8.3.1. Dual Chamber ICDs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Biventricular Devices
8.4.1. Biventricular Devices Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Implantable Cardioverter Defibrillators Market: NYHA Class Estimates & Trend Analysis
9.1. NYHA Class Segment Opportunity Analysis
9.2. NYHA Class II
9.2.1. NYHA Class II Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. NYHA Class III
9.3.1. NYHA Class III Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Implantable Cardioverter Defibrillators Market: End-user Estimates & Trend Analysis
10.1. End-user Segment Opportunity Analysis
10.2. Hospitals
10.2.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Ambulatory Surgical Centers
10.3.1. Ambulatory Surgical Centers Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.4. Others
10.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Regional Market Analysis
11.1. Regional Market Opportunity Analysis
12. North America Implantable Cardioverter Defibrillators Market
12.1. North America Implantable Cardioverter Defibrillators Market
12.1.1. North America Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. North America Implantable Cardioverter Defibrillators Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. North America Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
12.1.4. North America Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.1.5. North America Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
12.1.6. North America Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. U.S. Global Implantable Cardioverter Defibrillators Market
12.2.1. U.S. Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. U.S. Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
12.2.3. U.S. Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.2.4. U.S. Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
12.2.5. U.S. Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. Canada Global Implantable Cardioverter Defibrillators Market
12.3.1. Canada Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. Canada Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
12.3.3. Canada Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.3.4. Canada Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
12.3.5. Canada Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Europe Global Implantable Cardioverter Defibrillators Market
13.1. Europe Global Implantable Cardioverter Defibrillators Market
13.1.1. Europe Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
13.1.4. Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.1.5. Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
13.1.6. Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Germany Global Implantable Cardioverter Defibrillators Market
13.2.1. Germany Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Germany Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
13.2.3. Germany Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.2.4. Germany Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
13.2.5. Germany Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. UK Global Implantable Cardioverter Defibrillators Market
13.3.1. UK Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. UK Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
13.3.3. UK Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.3.4. UK Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
13.3.5. UK Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. France Global Implantable Cardioverter Defibrillators Market
13.4.1. France Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. France Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
13.4.3. France Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.4.4. France Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
13.4.5. France Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. Spain Global Implantable Cardioverter Defibrillators Market
13.5.1. Spain Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Spain Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
13.5.3. Spain Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.5.4. Spain Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
13.5.5. Spain Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Italy Global Implantable Cardioverter Defibrillators Market
13.6.1. Italy Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Italy Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
13.6.3. Italy Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.6.4. Italy Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
13.6.5. Italy Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Europe Global Implantable Cardioverter Defibrillators Market
13.7.1. Rest of Europe Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
13.7.5. Rest of Europe Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Asia Pacific Global Implantable Cardioverter Defibrillators Market
14.1. Asia Pacific Global Implantable Cardioverter Defibrillators Market
14.1.1. Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
14.1.4. Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.1.5. Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
14.1.6. Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Japan Global Implantable Cardioverter Defibrillators Market
14.2.1. Japan Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Japan Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
14.2.3. Japan Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.2.4. Japan Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
14.2.5. Japan Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. China Global Implantable Cardioverter Defibrillators Market
14.3.1. China Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. China Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
14.3.3. China Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.3.4. China Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
14.3.5. China Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. India Global Implantable Cardioverter Defibrillators Market
14.4.1. India Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. India Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
14.4.3. India Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.4.4. India Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
14.4.5. India Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. South Korea Global Implantable Cardioverter Defibrillators Market
14.5.1. South Korea Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. South Korea Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
14.5.3. South Korea Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.5.4. South Korea Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
14.5.5. South Korea Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.6. Australia Global Implantable Cardioverter Defibrillators Market
14.6.1. Australia Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.6.2. Australia Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
14.6.3. Australia Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.6.4. Australia Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
14.6.5. Australia Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.7. Rest of Asia Pacific Global Implantable Cardioverter Defibrillators Market
14.7.1. Rest of Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.7.2. Rest of Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
14.7.3. Rest of Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.7.4. Rest of Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
14.7.5. Rest of Asia Pacific Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. Latin America Global Implantable Cardioverter Defibrillators Market
15.1. Latin America Global Implantable Cardioverter Defibrillators Market
15.1.1. Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
15.1.4. Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.1.5. Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
15.1.6. Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. Brazil Global Implantable Cardioverter Defibrillators Market
15.2.1. Brazil Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. Brazil Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
15.2.3. Brazil Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.2.4. Brazil Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
15.2.5. Brazil Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. Mexico Global Implantable Cardioverter Defibrillators Market
15.3.1. Mexico Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. Mexico Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
15.3.3. Mexico Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.3.4. Mexico Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
15.3.5. Mexico Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Argentina Global Implantable Cardioverter Defibrillators Market
15.4.1. Argentina Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Argentina Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
15.4.3. Argentina Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.4.4. Argentina Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
15.4.5. Argentina Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.5. Rest of Latin America Global Implantable Cardioverter Defibrillators Market
15.5.1. Rest of Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.5.2. Rest of Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
15.5.3. Rest of Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.5.4. Rest of Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
15.5.5. Rest of Latin America Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. MEA Global Implantable Cardioverter Defibrillators Market
16.1. MEA Global Implantable Cardioverter Defibrillators Market
16.1.1. MEA Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
16.1.4. MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.1.5. MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
16.1.6. MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.2. GCC Global Implantable Cardioverter Defibrillators Market
16.2.1. GCC Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. GCC Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
16.2.3. GCC Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.2.4. GCC Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
16.2.5. GCC Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.3. South Africa Global Implantable Cardioverter Defibrillators Market
16.3.1. South Africa Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. South Africa Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
16.3.3. South Africa Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.3.4. South Africa Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
16.3.5. South Africa Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.4. Rest of MEA Global Implantable Cardioverter Defibrillators Market
16.4.1. Rest of MEA Implantable Cardioverter Defibrillators Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. Rest of MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By Product Type, 2023-2034 (Revenue USD Bn)
16.4.3. Rest of MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.4.4. Rest of MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By NYHA Class, 2023-2034 (Revenue USD Bn)
16.4.5. Rest of MEA Implantable Cardioverter Defibrillators Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17. Competitor Analysis
17.1. Company Market Share Analysis, 2023
17.2. Major Recent Developments
18. Company Profiles
18.1. Medtronic plc
18.2. Boston Scientific Corporation
18.3. Abbott Laboratories
18.4. BIOTRONIK SE & Co. KG
18.5. MicroPort Scientific Corporation
18.6. LivaNova PLC
18.7. Koninklijke Philips N.V.
18.8. ZOLL Medical Corporation
18.9. Stryker Corporation
18.10. Nihon Kohden Corporation
18.11. Physio-Control
18.12. Defibtech, LLC
18.13. Cardiac Science Corporation
18.14. Schiller AG
18.15. Mindray Medical International Limited
19. Conclusion20. Recommendations

Companies Mentioned

  • MicroPort Scientific Corporation
  • LivaNova PLC
  • Koninklijke Philips N.V.
  • ZOLL Medical Corporation
  • Stryker Corporation
  • Nihon Kohden Corporation
  • Physio-Control
  • Defibtech LLC
  • Cardiac Science Corporation
  • Schiller AG
  • Mindray Medical International Limited.

Table Information